Johnson & Johnson Innovation is expanding its strategy to include a new initiative in Europe designed to identify and nurture early-stage research companies. The collaboration with Janssen Pharmaceutica will be called Johnson & Johnson Innovation, JLINX (JLINX) and aims to offer start-ups flexible ways to grow and collaborate across the European life sciences.   JLINX will be located in a dedicated facility on the Janssen campus in Beerse, Belgium, and will be managed in close collabor...